Skip to main content
. 2019 Jan 7;6(1):e000307. doi: 10.1136/vetreco-2018-000307

Table 3.

Antimicrobial resistance phenotype and characterisation by whole genome sequencing (WGS) of 29 E coli isolates from 84 cross-sectional study participants, ordered by MLST sequence type

Isolate (participant†) Phenotype MDR ESBL (3GCR) ST Serotype Plasmid type Antimicrobial Resistance Genes Virulence Genes
101 (F18) AmpChlNalCipTmpTet Y –-(–) 10 (CC-10) O9:H9 IncF RST F67:A6:B38 aadA1, blaTEM-1A, dfrA1, floR, strA, strB, sul2, tet(A), tet(B) astA, gad, mchB, mchC, mchF
380 (S74) AmpNalCipTmpTet Y 10 (CC-10) H4 Col(MP18)*; Col(BS512); Col156*; IncI1(ST-3); blaTEM-1B, dfrA1, QnrB19, sul2, tet(A) gad
386 (S76) AmpNalTmpTet Y 13 (CC-13) H8 Col(MP18)*; IncB/O/K/Z*; IncF RST C3*:A-:B1, IncQ1; aadA1, blaTEM-1B, dfrA1, strA, strB, sul1, sul2, tet(A) gad, iha, iss, lpfA
59 (F11) TmpTet N – (–) 58 O9:H25 Col156; IncF RST F4:A-:B1; IncQ1 aph(3')-Ia, blaTEM-1B, dfrA5, strA, strB, sul2, tet(A) air, capU, gad, iha, ireA, iroN, iss, lpfA, mchF, mcmA, senB
36 (F04) AmpTmpTet Y
(–)
59 (CC-59) H7 Col156*; IncF RST F4:A-:B10 blaTEM-1C, dfrA17, tet(A) air, capU, eilA, gad, iha, lpfA, sat, senB
161 (F30) AmpTmpTet Y – (–) 69 (CC-69) H1 Col156*, IncF RST F87*:A4:B10, IncI1(ST-242)* aadA5, blaTEM-1B, dfrA17, sul1 air, gad, iss, lpfA, senB
181 (E33) AmpNalTmpTet Y – (–) 69 (CC-69) O15:H18 Col156*; IncB/O/K/Z; IncF RST F52:A6*:B48, IncI1 Incomplete ST; IncQ1; blaTEM-1B, dfrA7, strA, strB, sul1, sul2, tet(A) air, celb, eilA, gad, iha, ireA, iroN, iss, lpfA
121 (F22) AmpChlTet Y – (–) 88 (CC-23) O9:H19 IncF RST F2:A-:B-, IncI1 Unknown ST, IncI2* aadA1, catA1, strA, strB, tet(B) gad, iss, lpfA, mcmA
299 (S59) Amp N Y (Y) 127 O6:H31 Col(BS512); Col(MG828)*; Col156*; IncB/O/K/Z; IncF RST F29:A-:B10, IncI1 Incomplete ST; IncX1*; aadA5, aadA15, blaCTX-M-14, blaTEM-1A, cml, dfrA12, strB, sul1, tet(B) celb, gad, ireA, iss, lpfA, senB, vat
350 (S68) AmpNalCip N Y (Y) 131 O25:H4 Col(BS512); Col156*; IncF RST F1:A2:B20 blaCTX-M-27 gad, iha, iss, sat, senB
151 (S27) AmpTmpTet Y – (–) 141 H6 IncI1(ST223*); IncX1*; p0111*; aac(3)-IIa, aadA1, aph(3')-Ia, blaTEM-1B, dfrA1, strA, strB, sul2, tet(A) astA, gad, iroN, iss, mchB, mchC, mchF, mcmA, vat
229 (E42) AmpChlTmpTet Y – (–) 141 O50/O2:H6 IncF RST F40:A-:B-, IncQ1; aac(3)-IId, aac(6')Ib-cr, aacA4, ARR-3, blaTEM-1B, catA1, catA2, dfrA12, mph(E), msr(E), strA, strB, sul1, sul2, tet(A) cba, cma, gad, iroN, iss, mchB, mchC, mchF, mcmA, vat
200 (E38) AmpChlNalCipTmpTet Y Y (Y) 405 (CC-405) H6 IncF RST F1:A1:B49, IncQ1; aac(3)-IId, aac(6')Ib-cr, aadA5, blaCTX-M-15, blaOXA-1, blaTEM-1B, catB4, dfrA17, mph(A), strA, strB, sul1, sul2, tet(B) air, gad
288 (S57) AmpAmcChlNalCipTmpTet Y Y (Y) 405 (CC-405) O102:H6 Col(BS512); Col156*;
IncF RST F87*:A4:B1, p0111*;
aac(6')Ib-cr, aadA5, blaCTX-M-15, blaOXA-1, catB4, dfrA17, mph(A), strB, sul1, tet(B) air, celb, eilA, gad, iha, ireA, iroN, iss, lpfA
254 (E49) AmpAmcChlNalCipTmp Y – (–) 410 (CC-23) H9 IncI1(ST-26*) aadA1, blaOXA-1, blaTEM-33, floR, sul1, sul2 gad, lpfA
258 (E49) AmpAmcNalCip N – (–) 410 (CC-23) H9 IncI1(ST-26*) aadA1, blaOXA-1, blaTEM-33, strB, sul1 gad, lpfA
12 (F03) AmpNalCip N Y (Y) 648 H6 IncF RST F4:A-:B52, p0111* aac(3)-IIa, aac(6')Ib-cr, blaCTX-M-15, blaOXA-1, blaTEM-1B, catB4 air, gad, lpfA, nfaE, sat
17 (F03) AmpNalCipTet Y – (–) 648 H6 IncF RST F4:A-:B52, p0111* aac(3)-IIa, aac(6')Ib-cr, blaCTX-M-15, blaOXA-1, blaTEM-1B, catB4 air, eilA, gad, lpfA, nfaE, sat
91 (F16) AmpChlNalCipTmpTet Y – (–) 744 O89:H10 IncHI1(ST6*), IncQ1 aadA5, aph(3')-Ia, blaTEM-1B, catA1, dfrA17, mph(A), strA, strB, sul1, sul2, tet(B) gad, lpfA, pic, senB, vat
175 (F32) AmpAmcTmpTet Y – (–) 778 H18 IncF RST F1:A1*:B1, IncQ1 blaTEM-1B, dfrA14, dfrA8, mph(A), strA, strB, sul2, tet(A) aap, astA, gad, iss, nfaE
331 (S64) AmpAmc N N (Y) 963 H18 Col(BS512)*; Col156*; IncF RST F29:A-:B10 blaCMY-2 air, gad, senB
05 (F01) AmpAmcChlNalTmpTet Y – (–) 1861 O16:H5 Col(BS512), IncF RST F31*:A-:B10*, IncI1 Incomplete ST dfrA17 gad, lpfA, pic, senB, vat
199 (E37) AmpNalTet Y – (–) 2076 O17/44:H18 IncF RST F77:A-:B12* blaTEM-1B air, capU, celb, eilA, gad, lpfA
266 (F51) AmpAmcNalCip N N (Y) 3944 O8:H2 IncI1(ST-12); IncY* blaCMY-2 gad
267 (F51) AmpAmcChlNalCipTmp Y N (Y) 3944 O8:H2 IncI1(ST-12); IncX1*; IncY* aadA1, aadA2, blaCMY-2, cmlA1, dfrA12, sul3 gad
73 (F13) AmpAmcNalTmpTet Y – (–) 6899 H18 IncF RST F40:A-:B-, IncN(ST3) blaTEM-1B, QnrS1, strA, strB, sul2, tet(A) air, eilA, gad, iss, lpfA
123 (F22) AmpAmcChlNalCipTmpTet Y – (–) Unknown O9 IncF RST F-:A-:B38 aadA1, dfrA1, strB, sul1, sul2, tet(B) astA, gad, iss
131 (E24) AmpChlTet Y – (–) Unknown Unknown IncHI1(ST11*) blaSHV-40, fosA None Detected
411 (E79) Amp N N (N) Unknown Unknown IncF RST F-:A-:B50* None Detected gad, iss

*Allelic match of <100%.

† Letter in front of participant’s ID number indicates workplace (E = equine hospital, S =small animal hospital, F =farm animal hospital).

–, not tested; 3GCR, resistance to at least one third-generation cephalosporin on double disc diffusion testing; Amc, amoxicillin clavulanate resistance; Amp, ampicillin resistance; CC, clonal complex; Chl, chloramphenicol resistance; Cip, ciprofloxacin resistance; ESBL, phenotypic ESBL-producer on double disc diffusion testing; MDR, multidrug resistance; n, no; Nal, nalidixic acid resistance; ST, sequence type; Tmp, trimethoprim resistance; Tet, tetracycline resistance; Y, yes.